WuXI STA

About WuXI STA

WuXi STA, a subsidiary of WuXi AppTec, is a leading CRDMO providing integrated CMC services including both API and drug product for small molecule, oligonucleotide, peptide and complex conjugate from discovery to development and commercial manufacturing.

WuXi STA has 12 R&D and manufacturing sites across Asia, North America and Europe. With the industry-leading integrated CMC platform and the global quality system inspected by all major regulatory agencies, we have supported 35 new drugs approved globally since 2017. The products manufactured by WuXi STA have been launched in 105 countries around the world.

  • CN
  • 2015
    On CPHI since
  • 1000 - 4999
    Employees
Company types
Contract Service
Contact info
Meet us at

CPHI Frankfurt 2022

Messe Frankfurt, Germany
1-3 November 2022

Products from WuXI STA (15)

  • Formulation and drug product development and manufacturing

    Product Formulation and drug product development and manufacturing

    WuXi STA offers end-to-end drug product development and manufacturing for oral and injectable dosage forms from preclinical to commercial.  With over 1,192 formulators and analytical scientists we have delivered 1,704 pre-formulation molecules, 275 formulations and 638 batches in H1 of 2021 alone. Our te...
  • API and advanced intermedates development and manufacturing

    Product API and advanced intermedates development and manufacturing

    With our global standard quality system, we are uniquely positioned to be your strategic manufacturing partner for reliable, cost effective long-term supplies of your intermediates and APIs from a few grams to metric tons. Our unique"end-to-end" platform ensures knowledge retention throughout your product lif...
  • Oligonucleotide, Peptide and Complex Conjugates development and manufacturing

    Product Oligonucleotide, Peptide and Complex Conjugates development and manufacturing

    WuXi STA vertically integrated new modality platform, powered by WuXi Chemistry with both solid phase synthesis and liquid phase synthesis offers API to Formulation services including comprehensive analytical capability and know-how.

    Oligonucleotide CRDMO platform from customized monomers, l...
  • Pre-formulation development

    Product Pre-formulation development

    WuXi STA's IND Enabling Preformulation Package (IEPP) is an integrated end-to-end developability assessment service for new chemical entities (NCE). Efficiently identify challenges and solutions earlier for higher success rates and lower overall costs. PK formulation, Profiling, Form selection, and ...
  • Formulation development

    Product Formulation development

    WuXi STA's formulation development team is led by industry veterans with years of large pharma experience developing solutions for a wide range of molecules. Our teams will customize our diverse expertise to guide you to optimal formulation suitable for scale-up to help you reach patients fast and cost-effect...
  • Bioavailability enhancement and advanced delivery technologies

    Product Bioavailability enhancement and advanced delivery technologies

    Bioavailability Toolbox:Spray-dried dispersion (SDD) - preclinical to commercial scale
    Hot melt extrusion (HME)
    Nano suspension
    Softgel & Liquid filled capsules
    Injectable
  • Peptide Process Development and Manufacturing

    Product Peptide Process Development and Manufacturing

    WuXi STA Peptide platform services include: Process R&D, Manufacturing grams to kilograms peptides under cGMP, Analytical characterization, method development and validation, IPC & release testing, ICH compliant stability studies, Regulatory (CMC) submission support. Our platform support a wide variet...
  • Oligonucleotide Process Development and Manufacturing

    Product Oligonucleotide Process Development and Manufacturing

    WuXi STA has an integrated Oligo API process R&D and manufacturing platform from preclinical to commercial, operating at our US FDA inspected integrated process R&D and manufacturing facility based in Changzhou, China. We support the development and manufacture of a variety of oligonucleotide modaliti...
  • Highly potent API and ADC payload and payload-linker manufacturing

    Product Highly potent API and ADC payload and payload-linker manufacturing

    WuXi STA's Jinshan site and WuXi STA's Changzhou site are equipped with a R&D labs, a cGMP HP Kilo lab, and cGMP plant for handling highly potent APIs (HPAPIs) and antibody drug conjugate (ADC) payloads and payload-linkers. We offer drug product manufacturing at STA’s Shanghai Waigaoqi...
  • Analytical development

    Product Analytical development

    WuXi STA extend our analytical  services throughout the product life cycle including; Analytical method development and validation,  API and drug product release testing, Reference standard characterization and qualification, Genotoxic/elemental impurities method development, validation an...
  • In vivo pk

    Product In vivo pk

    WuXi STA drug product preformulation and formulation services and solutions can includes in vivo pk  with multiple animal species and fast turnaround.
  • Analytical chemistry

    Product Analytical chemistry

    WuXi STA's analytical support from laboratory process development to production through to regulatory data submission. Our dedicated analytical science and quality control teams provide our clients with a full spectrum of analytical method development, validation and testing services to support your needs fro...

WuXI STA Resources (10)